Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript

Core Viewpoint - The company is focused on executing high-level commercial and financial strategies while aiming for growth in 2029 and 2030 [1]. Group 1: Financial Performance and Strategy - The company has made significant progress in delivering on its financial promises [1]. - A total of $7.7 billion in cost improvements have been identified to enhance the cost structure over the next several years [2]. - The company is strategically rightsizing its operations in anticipation of a period of Loss of Exclusivity (LOE) [2].